- Anticoagulation with warfarin remains the first line treatment
- Aspirin and combined antiplatelet therapy are not nearly as effective as warfarin
- Agents are being tested to replace warfarin (eg Ximelagratan, a direct thrombin inhibitor) but there is risk of liver toxicity
- Surgical techniques (ligation atrial appendage or catheter ablation) are not alternatives to warfarin
- Left atrial appendage occlusion by the catheter technique may prove to be a safe alternative for those who can't or won't take warfarin (the PROTECT atrial fibrillation study is ongoing)
Source: Heart 2008;94:1113-1116
沒有留言:
張貼留言